These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30810268)

  • 1. High-Affinity Antibody Detection with a Bivalent Circularized Peptide Containing Antibody-Binding Domains.
    Zhou F; Kroetsch A; Nguyen VP; Huang X; Ogoke O; Parashurama N; Park S
    Biotechnol J; 2019 May; 14(5):e1800647. PubMed ID: 30810268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal fusion of antibody binding domains resulted in higher affinity and wider specificity.
    Dong J; Kojima T; Ohashi H; Ueda H
    J Biosci Bioeng; 2015 Nov; 120(5):504-9. PubMed ID: 25910963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative binding of disulfide-bridged PEG-Fabs.
    Khalili H; Godwin A; Choi JW; Lever R; Brocchini S
    Bioconjug Chem; 2012 Nov; 23(11):2262-77. PubMed ID: 22994419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications for an engineered Protein-G variant with a pH controllable affinity to antibody fragments.
    Bailey LJ; Sheehy KM; Hoey RJ; Schaefer ZP; Ura M; Kossiakoff AA
    J Immunol Methods; 2014 Dec; 415():24-30. PubMed ID: 25450256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomimetic Protein G affinity adsorbent: an Ugi ligand for immunoglobulins and Fab fragments based on the third IgG-binding domain of Protein G.
    El Khoury G; Lowe CR
    J Mol Recognit; 2013 Apr; 26(4):190-200. PubMed ID: 23456743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-Specific Photolabeling of the IgG Fab Fragment Using a Small Protein G Derived Domain.
    Kanje S; von Witting E; Chiang SC; Bryceson YT; Hober S
    Bioconjug Chem; 2016 Sep; 27(9):2095-102. PubMed ID: 27491005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs.
    Junutula JR; Bhakta S; Raab H; Ervin KE; Eigenbrot C; Vandlen R; Scheller RH; Lowman HB
    J Immunol Methods; 2008 Mar; 332(1-2):41-52. PubMed ID: 18230399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity.
    Kwong KY; Baskar S; Zhang H; Mackall CL; Rader C
    J Mol Biol; 2008 Dec; 384(5):1143-56. PubMed ID: 18809410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivalent antibody phage display mimics natural immunoglobulin.
    Lee CV; Sidhu SS; Fuh G
    J Immunol Methods; 2004 Jan; 284(1-2):119-32. PubMed ID: 14736422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oriented Immobilization of Fab Fragments by Site-Specific Biotinylation at the Conserved Nucleotide Binding Site for Enhanced Antigen Detection.
    Mustafaoglu N; Alves NJ; Bilgicer B
    Langmuir; 2015 Sep; 31(35):9728-36. PubMed ID: 26273992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific fab fragment biotinylation at the conserved nucleotide binding site for enhanced Ebola detection.
    Mustafaoglu N; Alves NJ; Bilgicer B
    Biotechnol Bioeng; 2015 Jul; 112(7):1327-34. PubMed ID: 25678249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization for binding complex formation with site-directly immobilized antibodies enhancing detection capability of cardiac troponin I.
    Cho IH; Seo SM; Jeon JW; Paek SH
    J Biomed Biotechnol; 2009; 2009():104094. PubMed ID: 19809518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CH2 Domain of Mouse IgG3 Governs Antibody Oligomerization, Increases Functional Affinity to Multivalent Antigens and Enhances Hemagglutination.
    Klaus T; Bereta J
    Front Immunol; 2018; 9():1096. PubMed ID: 29875771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Avidity of bivalent antibodies. Problems of its experimental determination and theoretical evaluation].
    Bobrovnik SA; Demchenko MA; Komisarenko SV
    Ukr Biokhim Zh (1999); 2012; 84(3):111-20. PubMed ID: 22860408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilization and functional reconstitution of antibody Fab fragment by solid-phase refolding.
    Kumada Y; Hamasaki K; Nakagawa A; Sasaki E; Shirai T; Okumura M; Inoue M; Kishimoto M
    J Immunol Methods; 2013 Dec; 400-401():70-7. PubMed ID: 24177435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific covalent attachment of an engineered Z-domain onto a solid matrix: an efficient platform for 3D IgG immobilization.
    Yang HM; Bao RM; Cheng YZ; Tang JB
    Anal Chim Acta; 2015 May; 872():1-6. PubMed ID: 25892064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific photoconjugation of antibodies using chemically synthesized IgG-binding domains.
    Perols A; Karlström AE
    Bioconjug Chem; 2014 Mar; 25(3):481-8. PubMed ID: 24520805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.